Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-022936

CEO and Director bought 12,000 shares at $7.00 ($84,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meckler Jeffrey A CEO and Director 2021-09-14 Purchase +12,000 $7.00 $84,000 14,460 D
Open-market purchases · 12,000 sh · avg $7.00 · $84,000
Loading xslF345X03/ownership.xml…